Answers are grounded in this paper and cite their sources.
Background Benign thyroid cysts are common lesions that may cause compressive symptoms or cosmetic concerns. Surgery is a definitive treatment but carries potential risks. Simple aspiration has been associated with high recurrence rates, while ultrasound-guided percutaneous sclerotherapy using agents such as ethanol and polidocanol has emerged as a minimally invasive alternative with high success rate, we aimed to compare the safety and efficacy of ultrasound-guided percutaneous ethanol injection versus polidocanol injection in the management of benign thyroid cysts. Methods In this prospective randomized study, 30 patients with symptomatic benign thyroid cysts were treated with either 99% ethanol or 20% polidocanol under ultrasound guidance. Procedural parameters, complications, and pain scores using the visual analog scale (VAS) were recorded. After aspiration/sclerotherapy, the clinical and sonographic follow-up was performed at 1, 3, and 6 months. Clinical success was defined as ≥ 50% reduction in cyst volume with associated improvement of symptoms. Results Both groups demonstrated comparable technical and clinical success. Mean cyst volume reduction at 6 months exceeded 96% in both groups, with no statistically significant difference ( p > 0.05). Improvement in compressive and cosmetic symptoms was similar (92.9% in the ethanol group vs. 100% in the polidocanol group; p = 0.292). Procedural pain was significantly lower in the polidocanol group (VAS 2.87 ± 1.46) compared to the ethanol group (VAS 5.0 ± 1.0; p < 0.001). Thyroid function remained stable in both groups throughout follow-up. Residual cysts and the need for repeat sessions were more frequent in the polidocanol group (21.4% vs. 0%), approaching statistical significance ( p = 0.058). Conclusions Ultrasound-guided sclerotherapy using either ethanol or polidocanol is safe and effective for the treatment of benign thyroid cysts. Both agents give substantial volume reduction and symptom relief. Polidocanol is associated with significantly less procedural pain, whereas ethanol demonstrates a trend toward lower recurrence rates.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: